Total Payments
$12,913
2024 Payments
$1,073
Companies
40
Transactions
1,018
Medicare Patients
12,792
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$9,972 (77.2%)
Travel$2,271 (17.6%)
Consulting$519.40 (4.0%)
Gifts$90.00 (0.7%)
Education$60.00 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,972 | 1,005 | 77.2% |
| Travel and Lodging | $2,271 | 8 | 17.6% |
| Consulting Fee | $519.40 | 2 | 4.0% |
| Gift | $90.00 | 2 | 0.7% |
| Education | $60.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $4,639 | 516 | $0 (2020) |
| Medtronic, Inc. | $2,088 | 237 | $0 (2024) |
| Nalu Medical, Inc. | $1,772 | 10 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $718.71 | 45 | $0 (2024) |
| Amgen Inc. | $584.70 | 31 | $0 (2022) |
| PFIZER INC. | $503.28 | 65 | $0 (2023) |
| SPR Therapeutics, Inc | $274.25 | 8 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $235.40 | 16 | $0 (2021) |
| Boston Scientific Corporation | $214.53 | 6 | $0 (2024) |
| Saol Therapeutics Inc. | $160.98 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,073 | 65 | Medtronic, Inc. ($506.78) |
| 2023 | $1,294 | 73 | Medtronic, Inc. ($811.00) |
| 2022 | $1,511 | 63 | Nalu Medical, Inc. ($781.20) |
| 2021 | $2,228 | 149 | Nalu Medical, Inc. ($948.46) |
| 2020 | $1,036 | 132 | Medtronic USA, Inc. ($548.31) |
| 2019 | $2,322 | 192 | Medtronic USA, Inc. ($1,850) |
| 2018 | $2,027 | 169 | Medtronic USA, Inc. ($1,351) |
| 2017 | $1,422 | 175 | Medtronic USA, Inc. ($889.03) |
All Payment Transactions
1,018 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/04/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Pain management | ||||||
| 11/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 11/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/07/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.70 | General |
| 10/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/09/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/21/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $62.14 | General |
| Category: Pain management | ||||||
| 09/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/22/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 07/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Opioid Analgesic | ||||||
| 07/18/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/27/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 06/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: Opioid Analgesic | ||||||
| 06/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,128 | 19,721 | $2.8M | $489,937 |
| 2022 | 24 | 2,790 | 26,600 | $2.6M | $535,820 |
| 2021 | 25 | 3,243 | 31,230 | $3.1M | $651,671 |
| 2020 | 30 | 3,631 | 31,275 | $3.2M | $641,767 |
Total Patients
12,792
Total Services
108,826
Medicare Billing
$2.3M
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 476 | 646 | $751,275 | $146,845 | 19.5% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 19 | 37 | $169,312 | $43,322 | 25.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 89 | 91 | $203,820 | $42,159 | 20.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 281 | 329 | $357,075 | $36,836 | 10.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 143 | 186 | $149,730 | $33,069 | 22.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 81 | 155 | $77,760 | $27,205 | 35.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 86 | 112 | $90,160 | $19,307 | 21.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 64 | 104 | $95,342 | $17,972 | 18.8% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 25 | 25 | $52,712 | $11,217 | 21.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 44 | 73 | $78,650 | $10,290 | 13.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 58 | 97 | $39,375 | $8,909 | 22.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 42 | 42 | $88,875 | $8,728 | 9.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 86 | 97 | $78,085 | $7,686 | 9.8% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 64 | 99 | $16,335 | $7,678 | 47.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 37 | $36,934 | $7,155 | 19.4% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 21 | 34 | $19,795 | $6,810 | 34.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 107 | 112 | $46,480 | $6,747 | 14.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 39 | 58 | $55,328 | $5,821 | 10.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 278 | 339 | $13,560 | $5,818 | 42.9% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 21 | 21 | $31,395 | $5,208 | 16.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 53 | 62 | $49,910 | $4,615 | 9.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 34 | 52 | $49,400 | $4,094 | 8.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 17 | 17 | $38,336 | $3,604 | 9.4% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 34 | 65 | $31,590 | $2,830 | 9.0% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 16 | 27 | $13,600 | $2,726 | 20.0% |
About Dr. Jon Parks, MD
Dr. Jon Parks, MD is a Pain Medicine healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477544658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Parks, MD has received a total of $12,913 in payments from pharmaceutical and medical device companies, with $1,073 received in 2024. These payments were reported across 1,018 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($9,972).
As a Medicare-enrolled provider, Parks has provided services to 12,792 Medicare beneficiaries, totaling 108,826 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Wichita, KS
- Active Since 11/04/2005
- Last Updated 05/13/2019
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1477544658
Products in Payments
- INTELLIS (Device) $1,774
- Nalu Neurostimulation System (Device) $1,772
- N'VISION (Device) $1,654
- INTELLIS ADAPTIVESTIM (Device) $1,142
- RESTORE (Device) $642.06
- Aimovig (Biological) $550.16
- XTAMPZA (Drug) $506.82
- LYRICA (Drug) $461.79
- KYPHON Balloon Kyphoplasty (Device) $455.40
- ADAPTIVESTIM (Device) $310.79
- SPRINT PNS System (Device) $274.25
- Horizant (Drug) $235.40
- Belbuca (Drug) $189.25
- ACCURIAN (Device) $143.61
- MYSTIM (Device) $139.50
- LIORESAL (BACLOFEN) (Drug) $120.00
- HA MINUTEMAN G3-R (Device) $115.96
- VANTA ADAPTIVESTIM (Device) $103.42
- GENERAL THERAPIES (Device) $99.81
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $97.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.